Press releases
- Press releases
- Browse
Press releases
New summary from Partneringdesk highlights trends in dealmaking from the top pharma and biotech companies More
A polymorphism in the PDCD1 involved in susceptibility for SLE More
Gene Bridges granted exclusive patent for Red®/ET® Recombination More
Target Validation for new drug discovery using large-scale functional genomics approaches More
CeNeS Pharmaceuticals plc (LSE:CEN) today noted recent press coverage on the identification of a risk gene for schizophrenia that has implications for its pre-clinical candidate rhGGF2, which is a recombinant version of the protein coded by that gene More
Related Reports
Market Research Reports provided by reports.iptechex.com
Dec 2010 - 15 pages - $500
Dec 2010 - 16 pages - $500
Mar 2011 - 34 pages - $500
Dec 2009 - 90 pages - $3,800
Nov 2011 - 6 pages - $75
Dec 2010 - 25 pages - $500
Mar 2011 - 26 pages - $500
Nov 2010 - 56 pages - $600
Nov 2010 - 88 pages - $600
Mar 2011 - 42 pages - $500
Your selection
Browse By
- Therapeutic target
- Ayuverdic medicine
- Chinese medicine
- Dietetic
- Homeopathy
- Iron excess
- Kanpo medicine
- Other
- Year
- 2013
- 2012
- 2011
- 2010
- 2009
- 2008
- 2007
- 2006
- 2005
- 2004
- 2003
- 2002
- 2001
- 2000
- 1999
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us